REFERENCES

• PertweeR.ed.Handbook of Cannabis. Oxford University Press; 2014. Available at: http://www.oxfordscholarship.eom/view/10.1093/acprof:oso/9780199662685.001.0001/acprof-9780199662685. Published online January 2015. Accessed May 21,2017
   Google Scholar
• VolkowN.ComptonW.WeissS.Adverse health effects of marijuana use.N Engl J Med.20143719879
   PubMed Web of Science ®Google Scholar
• NiesinkR.van LaarM.Does cannabidiol protect against adverse psychological effects of THC?Front Psychiatry.2013413024137134
   PubMedGoogle Scholar
• ElSohlyM.MehmedicZ.FosterS.GonC.ChandraS.ChurchJ.Changes in cannabis potency over the last 2 decades (1995-2014): analysis of current data in the United States.Biol Psychiatry.201679761361926903403
   PubMed Web of Science ®Google Scholar
• ZamengoL.PrisonG.BettinC.SciarroneR.Cannabis potency in the Venice area (Italy): update 2013.Drug Test Anal.20157325525825069834
   PubMed Web of Science ®Google Scholar
• NiesinkR.RigterS.KoeterM.BruntT.Potency trends of 9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15: potency trends of Dutch cannabis.Addiction.2015110121941195026234170
   PubMed Web of Science ®Google Scholar
• Di FortiM.SallisH.AllegriF.et alDaily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.Schizophr Bull.20144061509151724345517
   PubMed Web of Science ®Google Scholar
• HallW.DegenhardtL.High potency cannabis: a risk factor for dependence, poor psychosocial outcomes, and psychosis.BMJ.2015350h120525739398
   PubMedGoogle Scholar
• SchubartC.SommerI.van GastelW.GoetgebuerR.KahnR.BoksM.Cannabis with high cannabidiol content is associated with fewer psychotic experiences.Schizophr Res.20111301-321622121592732
   PubMed Web of Science ®Google Scholar
• JohnsonL.JohnsonR.PortierR.Current “legal highs.”J Emerg Med.20134461108111523528960
   PubMed Web of Science ®Google Scholar
• MillsB.YepesA.NugentK.Synthetic cannabinoids.Am J Med Sci.20153501596226132518
   PubMed Web of Science ®Google Scholar
• SarpongI.JonesF.A critical analysis of national policy relating to legal highs.Nurs Stand.201428523541
   PubMedGoogle Scholar
• ScocardA.BenyaminaA.CoscasS.KarilaL.Cannabinoïdes de synthase: une nouvelle matrice des addictions.Presse Med.2017461112228063756
   PubMedGoogle Scholar
• SeelyK.PattonA.MoranC.et alForensic investigation of K2, Spice, and “bath salt” commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.Forensic Sci int.20132331-341642224314548
   PubMed Web of Science ®Google Scholar
• FattoreL.Synthetic cannabinoids — further evidence supporting the relationship between cannabinoids and psychosis.Biol Psychiatry.201679753954826970364
   PubMed Web of Science ®Google Scholar
• CastellanosD.GralnikL.Synthetic cannabinoids 2015: an update for pediatricians in clinical practice.World J Clin Pediatr.201651162426862498
   PubMedGoogle Scholar
• FantegrossiW.MoranJ.Radominska-PandyaA.PratherP.Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to'-THC: mechanism underlying greater toxicity?Life Sci.2014971455424084047
   PubMed Web of Science ®Google Scholar
• De LucaM.CastelliM.LoiB.et alNative CB1 receptor affinity, intrinsic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS135.Neuropharmacology.201610563063826686391
   PubMed Web of Science ®Google Scholar
• CottencinO.RollandB.KarilaL.New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature.Curr Pharm Des.201420254106411124001292
   PubMed Web of Science ®Google Scholar
• DebruyneD.Le BoisselierR.Emerging drugs of abuse: current perspectives on synthetic cannabinoids.Subst Abuse Rehabil.2015611312926543389
   PubMed Web of Science ®Google Scholar
• AuwärterV.DresenS.WeinmannW.MullerM.PutzM.FerreirosN.“Spice” and other herbal blends: harmless incense or cannabinoid designer drugs?J Mass Spectrom.200944583283719189348
   PubMed Web of Science ®Google Scholar
• GurneyS.ScottK.KacinkoS.PresleyB.LoganB.Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs.Forensic Sci Rev.2014261537826226970
   PubMedGoogle Scholar
• MounteneyJ.GriffithsP.SedefovR.NoorA.VicenteJ.SimonR.The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015.Addiction.20161111344826419329
   PubMed Web of Science ®Google Scholar
• ArcherJ.DarganP.LeeH.HudsonS.WoodD.Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances.Clin Toxicol.2014523160165
   PubMed Web of Science ®Google Scholar
• NelsonM.BryantS.AksS.Emerging drugs of abuse.Emerg Med Clin North Am.201432112824275167
   PubMed Web of Science ®Google Scholar
• GundersonE.HaugheyH.Ait-DaoudN.JoshiA.HartC.A survey of synthetic cannabinoid consumption by current cannabis users.Subst Abuse.2014352184189
   PubMed Web of Science ®Google Scholar
• AndréassonS.AllebeckP.EngströmA.RydbergU.Cannabis and schizophrenia. A longitudinal study of Swedish conscripts.Lancet Lond Engl.19872857414831486
   PubMed Web of Science ®Google Scholar
• GageS.HickmanM.ZammitS.Association between cannabis and psychosis: epidemiologic evidence.Biol Psychiatry.201679754955626386480
   PubMed Web of Science ®Google Scholar
• MurrayR.Di FortiM.Cannabis and psychosis: what degree of proof do we require?Biol Psychiatry.201679751451526970362
   PubMed Web of Science ®Google Scholar
• IsegerT.BossongM.A systematic review of the antipsychotic properties of cannabidiol in humans.Schizophr Res.20151621-315316125667194
   PubMed Web of Science ®Google Scholar
• EnglundA.MorrisonP.NottageJ.et alCannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment.J Psychopharmacol Oxf Engl.20132711927
   PubMed Web of Science ®Google Scholar
• Di FortiM.MarconiA.CarraE.et alProportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.Lancet Psychiatry.20152323323826359901
   PubMed Web of Science ®Google Scholar
• SchoelerT.MonkA.SamiM.et alContinued versus discontinued cannabis use in patients with psychosis: a systematic review and metaanalysis.Lancet Psychiatry.20163321522526777297
   PubMed Web of Science ®Google Scholar
• FrisherM.CromeI.MacleodJ.MillsonD.CroftP.Substance misuse and psychiatric illness: prospective observational study using the general practice research database.J Epidemiol Community Health.2005591084785016166357
   PubMed Web of Science ®Google Scholar
• AounE.ChristopherP.IngrahamJ.Emerging drugs of abuse: clinical and legal considerations.R I Med J (2013).2014976414524905374
   PubMedGoogle Scholar
• TaitR.CaldicottD.MountainD.HillS.LentonS.A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.Clin Toxicol (Phila).201654111326567470
   PubMed Web of Science ®Google Scholar
• MüllerH.KornhuberJ.SperlingW.The behavioral profile of spice and synthetic cannabinoids in humans.Brain Res Bull.2016126pt 137
   Google Scholar
• UstundagM.Ozhan IbisE.YucelA.OzcanH.Synthetic cannabis-induced mania.Case Rep Psychiatry.20152015310930
   Google Scholar
• van AmsterdamJ.BruntT.van den BrinkW.The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.J Psychopharmacol (Oxf).2015293254263
   PubMed Web of Science ®Google Scholar
• ZaurovaM.HoffmanR.VlahovD.ManiniA.Clinical effects of synthetic cannabinoid receptor agonists compared with marijuana in emergency department patients with acute drug overdose.J Med Toxicol.201612433534027255136
   PubMed Web of Science ®Google Scholar
• TyndallJ.GeronaR.De PortuG.et alAn outbreak of acute delirium from exposure to the synthetic cannabinoid AB-CHMINACA.Clin Toxicol (Phila).2015531095095626555732
   PubMed Web of Science ®Google Scholar
• MörklS.BleslC.WurmW.TmavaA.Acute psychosis after consumption of synthetic cannabinoids. [in German].Fortschr Neurol Psychiatr.201684315015427029042
   PubMed Web of Science ®Google Scholar
• KhanM.PaceL.TruongA.GordonM.MoukaddamN.Catatonia secondary to synthetic cannabinoid use in two patients with no previous psychosis.Am J Addict.2016251252726781357
   PubMed Web of Science ®Google Scholar
• SpadernaM.AddyP.D'SouzaD.Spicing things up: synthetic cannabinoids.Psychopharmacology (Bed).20132284525540
   PubMed Web of Science ®Google Scholar
• ChavantF.BoucherA.Le BoisselierR.DeheulS.DebruyneD.New synthetic drugs in addictovigilance.Therapie.201570216718925858573
   PubMed Web of Science ®Google Scholar
• MilianoC.SerpelloniG.RimondoC.MereuM.MartiM.De LucaM.Neuropharmacology of new psychoactive substances (NPS): focus on the rewarding and reinforcing properties of cannabimimetics and amphetamine-like stimulants.Front Neurosci.20161015327147945
   PubMed Web of Science ®Google Scholar
• WellsD.OttC.The “new” marijuana.Ann Pharmacother.201145341441721325097
   PubMed Web of Science ®Google Scholar
• SampsonC.BedyS.CarlisleT.Withdrawal seizures seen in the setting of synthetic cannabinoid abuse. 4mJ Emerg Med.201533111712.e3
   Web of Science ®Google Scholar
• AndrabiS.GreeneS.MoukaddamN.MoukkadamN.LiB.New drugs of abuse and withdrawal syndromes.Emerg Med Clin North Am.201533477979526493523
   PubMed Web of Science ®Google Scholar
• NaccaN.VattiD.SullivanR.SudP.SuM.MarraffaJ.The synthetic cannabinoid withdrawal syndrome.J Addict Med.20137429629823609214
   PubMed Web of Science ®Google Scholar
• BushDM.WoodwellDA.Update: drug-related emergency department visits involving synthetic cannabinoids. Rockville, MD: US Substance Abuse and Mental Health Services Administration; 2013. The CBHSQ Report Available at: http://www.ncbi.nlm.nih.gov/books/NBK350768/. Published October 16, 2014. Accessed June 1,2017
   Google Scholar
• LabayL.CarusoJL.GilsonT.et alSynthetic cannabinoid drug use as a cause or contributory cause of death.Forensic Sci int.2016260313926795398
   PubMed Web of Science ®Google Scholar
• MurrayR.QuigleyH.QuattroneD.EnglundA.Di FortiM.Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis.World Psychiatr Assoc.2016153195204
   PubMed Web of Science ®Google Scholar
• RongC.LeeY.CarmonaN.et alCannabidiol in medical marijuana: research vistas and potential opportunities.Pharmacol Res.201712121321828501518
   PubMed Web of Science ®Google Scholar
• WatsonS.BensonJ.JoyJE.Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report.Arch Gen Psychiatry.200057654755210839332
   PubMed Web of Science ®Google Scholar
• SchrotR.HubbardJ.Cannabinoids: medical implications.Ann Med.201648312814126912385
   PubMed Web of Science ®Google Scholar
• WhitingP.WolffR.DeshpandeS.et alCannabinoids for medical use: a systematic review and meta-analysis.JAMA.2015313242456247326103030
   PubMed Web of Science ®Google Scholar
• KoppelB.BrustJ.FifeT.et alSystematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.Neurology.201482171556156324778283
   PubMed Web of Science ®Google Scholar
• GlossD.VickreyB.Cannabinoids for epilepsy.Cochrane Database Syst Rev.20143CD009270
   PubMed Web of Science ®Google Scholar
• DevinskyO.MarshE.FriedmanD.et alCannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.Lancet Neurol.201615327027826724101
   PubMed Web of Science ®Google Scholar
• O'ConnellB.GlossD.DevinskyO.Cannabinoids in treatment-resistant epilepsy: a review.Epilepsy Behav.201770pt B34134828188044
   PubMedGoogle Scholar
• SloanM.GowinJ.RamchandaniV.HurdY.Le FoilB.The endocannabinoid system as a target for addiction treatment: trials and tribulations.Neuropharmacology. 2017 May 28. Epub ahead of print. doi:10.1016/j.neuropharm.2017.05.031. Accessed June 4,2017
   Google Scholar
• HurdY.YoonM.ManiniA.et alEarly phase in the development of cannabidiol as a treatment for addiction: opioid relapse takes initial center stage.Neurother J Am Soc Exp Neurother.2015124807815
   Google Scholar
• Prud'hommeM.CataR.Jutras-AswadD.Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence.Subst Abuse.201593338
   PubMed Web of Science ®Google Scholar
• LewekeF.PiomelliD.PahlischF.et alCannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.Transl Psychiatry.201223e9422832859
   PubMed Web of Science ®Google Scholar
• BergamaschiM.QueirozR.ChagasM.et alCannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients.Neuropsychopharmacol.201136612191226
   PubMed Web of Science ®Google Scholar
• CrippaJ.DerenussonG.FerrariT.et alNeural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.J Psychopharmacol.201125112113020829306
   PubMed Web of Science ®Google Scholar
• BlessingE.SteenkampM.ManzanaresJ.MarmarC.Cannabidiol as a potential treatment for anxiety disorders.Neurother J Am Soc Exp Neurother.2015124825836
   Google Scholar
• BabsonK.SottileJ.MorabitoD.Cannabis, cannabinoids, and sleep: a review of the literature.Curr Psychiatry Rep.2017192328349316
   PubMed Web of Science ®Google Scholar
• ZuardiA.Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action.Rev Bras Psiquiatr Sao Paulo Braz 1999.2008303271280
   PubMed Web of Science ®Google Scholar
• ChagasM.CrippaJ.ZuardiA.et alEffects of acute systemic administration of cannabidiol on sleep-wake cycle in rats.J Psychopharmacol Oxf Engl.2013273312316
   PubMed Web of Science ®Google Scholar
• NicholsonA.TurnerC.StoneB.RobsonP.Effect of Δ9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults.J Clin Psychopharmacol.200424330531315118485
   PubMed Web of Science ®Google Scholar
• D'SouzaD.RanganathanM.Medical marijuana: is the cart before the horse?JAMA.2015313242431243226103026
   PubMed Web of Science ®Google Scholar